Skinvisible expands to India

Avani International will distribute Skinvisible's Invisicare technology and products in India, Skinvisible announces. Inviscare - which enhances the delivery of topical dermatology products on skin - was recently granted a comprehensive patent in India, the company says. Under the terms of the agreement, Avani will seek licenses in India for topical products such as hand sanitizers and items that treat acne, fungal infections and atopic dermatitis. The Indian firm also will facilitate clinical studies and manufacturing in the country. "It is important for Skinvisible to develop partnerships with companies such as Avani as they have established relationships with pharmaceutical and consumer goods companies in India. This helps us fast-track our marketing efforts in the country and generate license fees and royalties quicker than marketing in India ourselves," Terry Howlett, president and CEO of Skinvisible, says. The deal is part of Skinvisible's strategy for rapid global expansion